Correlation Between Pfizer and Cybin

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Cybin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Cybin into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Cybin Inc, you can compare the effects of market volatilities on Pfizer and Cybin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Cybin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Cybin.

Diversification Opportunities for Pfizer and Cybin

-0.55
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and Cybin is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Cybin Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cybin Inc and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Cybin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cybin Inc has no effect on the direction of Pfizer i.e., Pfizer and Cybin go up and down completely randomly.

Pair Corralation between Pfizer and Cybin

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Cybin. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 3.58 times less risky than Cybin. The stock trades about -0.15 of its potential returns per unit of risk. The Cybin Inc is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  760.00  in Cybin Inc on September 17, 2024 and sell it today you would earn a total of  231.00  from holding Cybin Inc or generate 30.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Cybin Inc

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Cybin Inc 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cybin Inc are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady fundamental drivers, Cybin displayed solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Cybin Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Cybin

The main advantage of trading using opposite Pfizer and Cybin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Cybin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cybin will offset losses from the drop in Cybin's long position.
The idea behind Pfizer Inc and Cybin Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum